| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-11 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.19 | 7e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |